The Case for and Against Buying NuScale Right Now

NuScale Power shares have fallen about 75% since last July, trading near $10 vs a 52-week high of $57, reflecting investor frustration over no commercial SMR sales despite NRC-certified design. The article cites tailwinds from U.S. government support for nuclear expansion (goal to quadruple capacity by 2050) and interest from AI-driven baseload demand, but highlights the key overhang: lack of a first firm reactor customer and limited projects beyond early discussions.

Analysis

The market is still pricing SMR like a policy-backed call option on AI power demand, but the economic bottleneck is not reactor design quality; it is bankability. Until there is a first firm order with real financing terms, the business remains a pre-revenue story where each quarter of delay raises the probability of dilution, customer hesitation, or a lower terminal multiple. That makes the stock highly sensitive to any gap between press-release momentum and executable project finance.

Second-order, the likely beneficiaries of the next 6-18 months are not the pure-play developers but the boring enablers: utilities with regulated rate bases, grid equipment, engineering firms, and uranium/fuel-cycle exposure. If SMR and peers keep talking while commercial deployment slips, capital will rotate toward names that can monetize AI electricity demand today rather than someday. The competitive threat is also real: if one non-NuScale design reaches financial close first, first-mover advantage can flip into an overhang as buyers anchor on proven rather than certified technology.

Near term, the stock can still squeeze on headline support, but that is a trade, not an investment thesis. The key falsifier is a signed, funded project with milestone payments; absent that, every rally should be treated as an opportunity for existing holders to reduce exposure. Over 1-3 months, watch for any first order, DOE grant, or partner equity commitment; over 6-18 months, watch for whether the company needs to raise capital before proving commercial economics. If commercialization does not materialize, the move lower is likely only partially complete.

Key Decisions for Investors

• Short SMR on strength or buy 1-3 month puts into any policy-driven pop; the thesis is that the stock still prices in commercialization optionality without proof of demand. Falsify if SMR announces a first firm, financed order with meaningful deposit and milestone structure.
• Pair trade: long XLU or a regulated-utility basket, short SMR, to express the view that AI power demand will monetize through existing grid owners before it monetizes through unproven SMR developers. Time horizon: 3-12 months; risk is a surprise project-finance close for SMR.
• For higher-risk accounts, sell SMR rallies into the $12-$15 area and keep a hard stop above the post-news breakout level; the risk/reward is favorable because downside is tied to dilution/absence of orders while upside requires multiple de-risking events.
• Set an alert for any non-binding MoU vs. binding FID distinction: only a funded EPC/utility commitment should reverse the bearish stance. If the next catalyst is merely another partnership announcement, fade it.